1995PubMedRequires access

[Benign monoclonal gammopathy].

Tsunemichi Shirota, Masateru Kondo, Hajime Uchida, H Ito

Open publisher page 0 citations

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in patients, without evidence of multiple myeloma, macroglobulinemia, amyloidosis or other related diseases. Differential diagnosis of MGUS from multiple myeloma is difficult in cases of the unusual type of each disease. A serum monoclonal protein concentration of less than 3 g/dl, normal polyclonal immunoglobulin, no or small amount of Bence Jones proteinuria and the infiltration of plasma cells of less than 10% in bone marrow are suggestive of MGUS. In the literature, about 25% of the MGUS have developed multiple myeloma or related diseases in a long term follow-up. This fact calls our attention to the management of MGUS.

About this research paper

What this paper is about

Monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in patients, without evidence of multiple myeloma, macroglobulinemia, amyloidosis or other related diseases. Differential diagnosis of MGUS from multiple myeloma is difficult in cases of the unusual type of each disease. A serum monoclonal protein concentration of less than 3 g/dl, normal polyclonal immunoglobulin, no or small amount of Bence Jones proteinuria and the infiltration of plasma cells of less than 10% in bone marrow are suggestive of MGUS. In the literature, about 25% of the MGUS have developed multiple myeloma or related diseases in a long term follow-up. This fact calls our attention to the management of MGUS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in patients, without evidence of multiple myeloma, macroglobulinemia, amyloidosis or other related diseases. Differential diagnosis of MGUS from multiple myeloma is difficult in cases of the unusual type of each disease. A serum monoclonal protein concentration of less than 3 g/dl, normal polyclonal immunoglobulin, no or small amount of Bence Jones proteinuria and the infiltration of plasma cells of less than 10% in bone marrow are suggestive of MGUS. In the literature, about 25% of the MGUS have developed multiple myeloma or related diseases in a long term follow-up. This fact calls our attention to the management of MGUS.

Key concepts: Monoclonal gammopathy of undetermined significance, Multiple myeloma, Bence Jones protein, Amyloidosis, Medicine, Macroglobulinemia, Myeloma protein, Waldenstrom macroglobulinemia

Related papers

Back to paper searchBrowse research topicsOriginal source
[Benign monoclonal gammopathy]. — Research Paper | ScholarLens